تصفح Pharmacy Research حسب الموضوع "cost saving"
السجلات المعروضة 1 -- 1 من 1
-
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes
( Taylor & Francis , 2024 , Article)Aim: To evaluate the cost-effectiveness of dapagliflozin added to standard of care (SoC) versus SoC in heart failure with reduced ejection fraction (HFrEF) and without type 2 diabetes mellitus (T2DM) patients from the ...